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Background: Risky drinking in pregnancy by UK women is likely to result in many alcohol-exposed pregnancies.
Studies from the USA suggest that brief intervention has promise for alcohol risk reduction in antenatal care.
However, further research is needed to establish whether this evidence from the USA is applicable to the UK. This
pilot study aims to investigate whether pregnant women can be recruited and retained in a randomized controlled
trial of brief intervention aimed at reducing risky drinking in women receiving antenatal care.
Methods: The trial will rehearse the parallel-group, non-blinded design and procedures of a subsequent definitive
trial. Over 8 months, women aged 18 years and over (target number 2,742) attending their booking appointment
with a community midwife (n = 31) in north-east England will be screened for alcohol consumption using the
consumption questions of the Alcohol Use Disorders Identification Test (AUDIT-C). Those screening positive, without
a history of substance use or alcohol dependence, with no pregnancy complication, and able to give informed
consent, will be invited to participate in the trial (target number 120). Midwives will be randomized in a 1:1 ratio to
deliver either treatment as usual (control) or structured brief advice and referral for a 20-minute motivational
interviewing session with an alcohol health worker (intervention). As well as demographic and health information,
baseline measures will include two 7-day time line follow-back questionnaires and the EuroQoL EQ-5D-3 L
questionnaire. Measures will be repeated in telephone follow-ups in the third trimester and at 6 months post-
partum, when a questionnaire on use of National Health Service and social care resources will also be completed.
Information on pregnancy outcomes and stillbirths will be accessed from central health service records before the
follow-ups. Primary outcomes will be rates of eligibility, recruitment, intervention delivery, and retention in the
study population, to inform power calculations for a definitive trial. The health-economics component will establish
how cost-effectiveness will be assessed, and examine which data on health service resource use should be
collected in a main trial. Participants’ views on instruments and procedures will be sought to confirm their
acceptability.
Discussion: The study will produce a full trial protocol with robust sample-size calculations to extend evidence on
effectiveness of screening and brief intervention.
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This project focuses on the reduction of risky alcohol
consumption during pregnancy. Risky drinking refers to
a level of consumption that increases the likelihood of
health problems (hazardous drinking), or that has
already caused such problems (harmful drinking), and a
pattern of high-intensity drinking associated with intoxi-
cation or drunkenness (binge drinking) [1]. Around a
third of women drink more than the medically recom-
mended levels [2]. Although older and more affluent
women tend to drink more frequently than younger and
less affluent women, the latter tend to binge drink
(around a fifth of women aged 16 to 44 years binge
drink [2]). Binge drinking is strongly associated with
sexual risk-taking and unintended pregnancy [3]. Around
a third of pregnancies are reported as unintended, but this
can be as high as 70% for single women [4] and 82% for
those living in impoverished, urban communities [5].
Thus a large number of pregnancies, particularly those in
women from lower socio-economic positions, are likely
to be significantly related to alcohol [6].
Although most women report that they abstained or
reduced alcohol consumption during pregnancy, 8% of
recently pregnant women report exceeding the medically
recommended guidelines for low-risk drinking in preg-
nancy [7]. Of the estimated 723,000 births registered in
England and Wales in 2010 [8], about 58,000 may have
been significantly exposed to alcohol. The teratogenic
effects of heavy alcohol consumption are well known [9].
Experts agree that there is a dose-dependent effect of
alcohol on fetal and child development [10]. In addition,
the timing of alcohol exposure is crucial [9]. Both the
first and third trimester of pregnancy in humans are
vulnerable periods for central nervous system development
[9,11,12]. Thus, although intervention before or very early
in pregnancy gives the best opportunity of reducing harm
to the developing fetus, reducing alcohol consumption at
any stage in pregnancy will have beneficial effects. The
likely under-reporting of fetal alcohol effects in the admis-
sions data of UK hospitals makes it unclear whether these
data are similar to the higher rates in deprived communities
reported from the USA [13-15].
Although recent UK government strategy aims to raise
awareness of health risks around alcohol use during
pregnancy [16], there is currently no formal program of
screening or alcohol intervention during antenatal care
in England. Although most women recall alcohol being
mentioned by midwives, this seems to have little effect
on their drinking behavior, in part because women perceive
that they often receive conflicting or unclear messages
from health professionals [7]. There is therefore a need for
clear, consistent, and effective alcohol advice in antenatal
care. A large and robust evidence base supports screening
and brief alcohol intervention in other populations. In thissecondary preventive strategy, based on social cognitive
and social learning theories, risky drinkers receive short
advice or counseling, focusing on both personal and
contextual factors to promote reduced drinking [17,18]. A
recent Cochrane Collaboration meta-analysis identified 29
randomized controlled trials (RCTs) in primary care, and
found consistent positive effects of brief interventions
compared with control conditions in terms of weekly
reductions in alcohol consumption [19]. However, the
authors noted that there was a lack of data relating specif-
ically to women. A more recent Cochrane Collaboration
review of pre-pregnancy health-promotion interventions
identified just one alcohol-specific trial [20], which was
based in the USA [21]. Although positive effects were
reported for brief intervention, these disappeared in the
sensitivity analysis [21]. Thus, brief intervention research
focused on antenatal care is urgently needed.
Five brief intervention trials have been conducted with
pregnant women in the USA [22-26]. Two trials were
small (pilot) studies [23,25], with assessment and/or
brief intervention procedures that were much longer in
duration (1 to 2 hours) than the time available in ante-
natal care in the UK [23-25]. Four trials were based in
obstetric settings [22-25], and three used specialist prac-
titioners to deliver brief intervention [22,24,25]. Two
trials included a single session of brief intervention, one
of 10 to 15 minutes [26] and the other of 25 minutes in
duration [23]. The former reported significant effects of
brief intervention [26], whereas the latter reported
reduced drinking in both the control and intervention
groups [23]. Finally, one study found that women in
antenatal care receiving brief interventions were signifi-
cantly less likely than women receiving no treatment to
have an infant with low birth weight or to suffer preterm
labor problems, while another study found positive
effects of brief intervention on prenatal drinking in
women with higher initial rates of consumption [22,23].
Most recently, a trial of brief interventions in antenatal
clinics in South Africa found that women who received
a brief intervention had significantly greater reductions
in scores on the Alcohol Use Disorders Identification
Test (AUDIT) screening tool [27] by their third trimes-
ter, compared with women receiving assessment only
[28]. Taken together, this evidence suggests that brief
intervention is a promising approach for alcohol risk
reduction in antenatal care. However, it is necessary to
establish if evidence from the USA and elsewhere is
applicable to a UK context with marked cultural and
health-system differences.
New guidance from the Medical Research Council on
developing and evaluating complex interventions [29] is
intended to help institute appropriate methods in such
research and to enhance the usefulness of its evidence.
The guidance points out the potential for evaluations of
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undermined by problems that could be highlighted in a
pilot study. Piloting is therefore recommended, but
should not be used to test a hypothesis [30]. The pilot
study should establish the acceptability of procedures,
identify likely recruitment and retention rates, and inform
a sample-size calculation for a definitive trial [29]. Because
brief interventions to reduce alcohol consumption have
not been tested previously in UK antenatal care, a pilot
study for such research is proposed on this basis.
Aim
This pilot study aims to investigate whether it is possible
to recruit and retain pregnant women in an RCT of brief
intervention aimed at reducing risky drinking in women
receiving antenatal care.
The information gathered from this intervention platform
research will inform the development and conduct of a
future definitive trial.
The specific objectives of this pilot trial are: 1) To
conduct an external (rehearsal) pilot RCT comparing
brief intervention with standard advice about alcohol in
antenatal care; 2) to estimate patient eligibility, recruit-
ment, randomization, retention, and response rates to
inform a future definitive trial; 3) to develop methods
and instruments for data collection for an economic
evaluation of brief intervention in a definitive trial; and
4) to develop the protocol for a definitive trial evaluating
the effect of brief alcohol intervention compared with
standard advice in antenatal care.
Methods/Design
Setting
The trial setting is that of community antenatal care.
Under National Health Service (NHS) antenatal care in
the UK [31], women initially receive advice from a
general practitioner (GP) or midwife about lifestyle,
folic-acid supplements, food hygiene, and antenatal
screening. A booking appointment subsequently takes
place during the first trimester at the woman’s home or
in a clinic at the GP surgery. At this meeting, the
community midwife provides more detailed information
on fetal development, procedures, and resources; carries
out assessments to develop an individual care plan; and
offers lifestyle advice, screening tests, and an ultrasound
scan (carried out at 18 to 20 weeks if desired). Appoint-
ments then take place every 2 to 3 weeks from week 25 of
pregnancy, in which the midwife carries out routine tests
and offers staged advice as appropriate.
For this study, midwives (n = 31) working from four
bases of a community midwifery service are recruiting
patients over an 8-month period from January 2012.
Between them, these midwives provide antenatal care
for 36 general practices in Newcastle upon Tyne innorth-east England (population 2,607,000; annual live
births 30,826), a geographical area with high rates of
alcohol misuse and a culture of heavy drinking [32-34].
The practices comprise 41 branch surgeries with diverse
patient profiles (total list size 282,034). Each practice is
served by one to three midwives and midwives may
routinely provide care to patients at one to three practices,
depending on practice list sizes and whether or not the
midwife works full-time.
Design
The pilot trial will rehearse the design and procedures
we currently envisage for a subsequent definitive trial,
and will thereby test their feasibility and acceptability. It
is a parallel-group, non-blinded trial, with midwife as
the unit of randomization, comparing 5 minutes of
structured advice from a community midwife plus a 20
minute brief intervention delivered by a trained alcohol
counselor (intervention group) with the standard advice
on drinking in pregnancy delivered by community mid-
wives (treatment as usual). The midwives take consent,
and deliver the screening and advice to patients (usual
standard care if allocated to control condition, structured
advice if allocated to the intervention condition), while a
trained alcohol counselor attached to the research team
delivers the 20 minute intervention (structured alcohol
advice and counseling) to patients in the intervention
group only. The brief alcohol intervention utilizes motiv-
ational interviewing techniques and a directive client-
centered approach, and focuses on both personal and
contextual factors in promoting behavior change. Our
hypothesis for the definitive RCT will be that brief inter-
vention is more effective and cost-effective at reducing
risky drinking in pregnant women than a control condi-
tion of usual advice in antenatal care.
Participants
Participants in this trial are women undergoing routine
antenatal care who screen positive for risky alcohol use.
Inclusion criteria
Any woman aged 18 years or above attending for her
routine antenatal care appointment before 16 weeks of
gestation who can and does provide verbal agreement to
be screened for alcohol, who screens positive for risky
alcohol use during pregnancy (score of three or higher
on the consumption domain of AUDIT (AUDIT-C))
[35], and who can and does give written consent to
participate in the research will be eligible for inclusion.
Exclusion criteria
Women are not eligible if they have pregnancy compli-
cations or have a multiple pregnancy; if they do not
speak sufficient English to participate, or lack the cognitive
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they have a history of substance use and/or alcohol
dependence; or if they are experiencing a severe mental or
physical illness likely to have an effect upon the interven-
tion or on their ability to be followed up. Finally, women
who are already participating in other alcohol-related
research are excluded from the study.
Randomization
In anticipation of the main trial employing a cluster
randomized design to avoid contamination, the unit of
randomization is the midwife. It is not practical for
individual midwives to deliver both control and interven-
tion conditions in this trial, as training to deliver structured
advice will compromise their ability to deliver treatment as
usual. Because community midwives may serve multiple
GP practices, each midwife consistently delivers either
intervention or treatment as usual.
Before screening of women for the trial, midwives
were randomized in a 1:1 ratio to either control or inter-
vention group with no concealment of allocation. They
were notified of their allocation and trained in the
appropriate procedures.
Screening
Participating midwives inform all women attending their
booking appointment about the research and complete
the AUDIT-C screening tool [35] with those women
who give verbal consent. In a recent systematic review,
AUDIT-C (comprising the first three questions of the
full AUDIT tool) was shown to have the best sensitivity
and specificity of seven screening instruments in identi-
fying problem drinking during pregnancy [36]. An anon-
ymized eligibility screening form is completed by the
midwife for all women to determine whether they
should be excluded from the study, in order to ascertain
any eligibility biases. A screening log is kept to document
non-identifiable characteristics of women invited to
participate in the study, in order to ascertain whether
there is any participation bias. The research team will
support midwives in implementing screening procedures
through weekly contact with each midwife base.
Consent
Community midwives will provide a study participant
information sheet to all pregnant women at their booking
appointment and explain the document. The patient is
allowed to keep this document. Owing to the small partici-
pant population, the information sheet and consent form
for the study are available in English only. Discussions to
allow informed consent take place between the midwives
and the potential participants, with opportunity for the
participants to ask any questions. Because women will
usually be asked about their alcohol consumption in thecourse of routine antenatal appointments, only verbal
consent is sought for screening.
Women eligible to participate in the trial are given a
reasonable time within the appointment to decide
whether or not they wish to do so. Those wishing to take
part are asked to provide written informed consent by
initialing, signing, and dating a study consent form,
which is witnessed and dated by a midwife with
documented, delegated responsibility to do so. Written
informed consent is always obtained before any study-
specific procedures including collection of baseline data.
The right to refuse to participate without giving reasons
is respected. The original signed consent form is retained
in the investigator site file, with a copy retained in
the clinical notes and another copy provided to the
participant. The participant is specifically asked to consent
to their GP being informed of their participation in the
study, so that the GP is aware of the research if the
woman discusses it during a GP consultation.
Interventions
Control condition: treatment as usual
Women in the control condition will receive usual care
delivered by the midwife. This involves the midwife
verbally advising that abstinence from alcohol during
pregnancy is recommended, and supplying a copy of the
Department of Health booklet The Pregnancy Book [37],
an advisory publication that is issued to all women in
the UK attending booking appointments and that contains
advice about alcohol use during pregnancy (on page 32). If
the midwife judges the reported rate of binge drinking or
current alcohol consumption to be of concern, a referral is
made to a drug and alcohol midwife for further assessment,
advice, or treatment.
Treatment as usual is delivered at the booking
appointment immediately after screening, obtaining written
consent, and completing the research questionnaire.
Brief intervention condition
Women in the intervention condition receive 5 minutes
of simple structured alcohol advice delivered by the
midwife, using a purposely designed brief advice tool
(see Additional file 1). They retain the advice tool and
receive a copy of The Pregnancy Book. If the midwife
judges the reported rate of binge drinking or current
alcohol consumption to be of concern, a referral is made
to a drug and alcohol midwife for further assessment,
advice, or treatment. These procedures take place at the
booking appointment immediately after screening,
obtaining written consent and completing the research
questionnaire.
Women are then advised by the midwife that a
member of the research team will contact them shortly
by telephone to offer an appointment for brief alcohol
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alcohol health worker. This intervention takes 20 minutes,
and is offered within 2 weeks of the initial consultation at
the woman’s GP surgery housing the antenatal clinic.
Training
Intervention midwives have been trained by the alcohol
counselor in the delivery of brief advice and provided
with a copy of the intervention manual; control mid-
wives will receive this training once follow-up interviews
are completed. The alcohol health worker has regular
contact with the intervention midwives to encourage
fidelity. The alcohol health worker has been fully trained
in delivery of the twenty minute intervention. This training
included assessment of competence using the Behavior
Change Counseling Index [38]. In addition, the alcohol
counselor will receive clinical supervision from the
consultant psychiatrist (EGilvarry) and management super-
vision from the project manager (GW). The alcohol
counselor will record all appointment durations along with
anonymized procedural notes on a case report form to
allow the consistency of length of delivery to be assessed.
Participant compliance
Where feasible, appointments with the alcohol counselor in
practices allocated to the intervention group will coincide
with routine clinical appointments within the antenatal
clinics, to enhance the likelihood of good compliance. The
second consultation is sought within 2 weeks of the initial
screening to maximize the likelihood that the participant
will return. Non-attendance at an intervention appoint-
ment, or non-compliance with an arranged follow-up
telephone interview (that is, not answering or not being
available at specified time) will prompt up to two follow-up
telephone calls from the project team to arrange an alterna-
tive appointment within 1 week. Participants’ receipt of
brief advice, attendance at intervention appointment,
receipt of intervention, and participation in follow-up inter-
views are recorded on a case report form. Participants will
not be offered incentives.
Measures
Baseline
The primary outcomes for this feasibility study are rates
of eligibility, recruitment, intervention delivery, and
participant retention at follow-up. Eligibility will be
established by midwives using a checklist of inclusion
and exclusion criteria and the AUDIT-C. Rates of
recruitment, intervention delivery, and retention will be
determined from case report forms. The alcohol
counselor will record whether the alcohol intervention
was delivered with the participant.
The trial will also measure the proposed outcomes for
a future main trial, allowing us to test the usefulness ofmeasures, obtain an estimate of variability to inform
power calculations, and assess the acceptability of trial
documents. The primary outcome in a full trial will be
the maximum number of standard drinks (units) per
drinking occasion during the pregnancy, a continuous
measure), with secondary outcomes including alcohol
abstinence (binary) in the third trimester and 6 months
post-partum. Participants will be asked to complete a
questionnaire containing three baseline measures, with
their midwife’s assistance if requested.
1 The Timeline Follow-Back (TLFB) questionnaire [39]
measures alcohol consumption during pregnancy for
two weekly periods. The respondent is asked to
complete a simple diary (with visual cues) detailing
alcohol use in the preceding week. The preceding
week might not be typical (for example, a patient
might have reduced their drinking as the booking
appointment approached), and there may be a
tendency to enhance social desirability in responses.
Thus, a second diary is requested covering the
heaviest drinking week since becoming pregnant. The
TLFB has been used as an outcome measure with
pregnant women [23,24,40] previously. Scores from
the 7-day version, which we will use to minimize the
burden on patients, have been found to be strongly
correlated with those gathered within longer
timeframes [41-43].
2 The AUDIT-C is completed in respect of the
participant’s drinking in the 6 months before
pregnancy, because the quantity and pattern of
previous drinking is predictive of whether or not
pregnant women drink during pregnancy [44]. In a
full trial, this information will establish whether
effects of the intervention differed according to the
level of pre-pregnancy drinking.
3 The EuroQoL EQ-5D-3 L instrument measuring
quality of life will be completed as part of the health-
economics analysis (see below).
The participant will be given time to complete these
questionnaires within the appointment before returning
them to the midwife, who will check for completeness
and prompt for completion if there are missing items.
The midwife will abstract data from the participant’s
booking notes on to a case report form, including the
participants’ health status (including lifestyle behavior
such as smoking and body mass index) and social
circumstances (marital and employment status, parity).
Non-identifiable residential postcode data will be abstracted
from contact details provided by trial participants to
derive socio-economic profile via the Index of Multiple
Deprivation [45]. This index, developed for the UK
government, constitutes a weighted area level aggregation
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may experience.
Follow-up
Six months after a baseline interview (during the third
trimester), the project manager ascertains whether the
participant has experienced a fetal loss or had pregnancy
complications diagnosed since her first trimester. In either
case, the participant will be excluded from follow-up data
collection and will not be contacted. This information will
be sought from the Regional Maternity Survey Office
(RMSO; http://www.nepho.org.uk/rmso/) and the commu-
nity midwife in order to minimize the risk of causing dis-
tress to the participant by inappropriate telephone contact.
The RMSO is a publicly funded organization supported by
clinical staff, which collects information from hospitals
across the north of England to monitor health outcomes
for mothers and babies. The project administrator contacts
participants who still meet the criteria for inclusion in their
third trimester to arrange a telephone interview with the
project manager (GW). In the interview, the project
manager will administer the 7-day TLFB questionnaire, the
EQ-5D-3 L, and a NHS service use questionnaire. We will
also check whether participant follow-up rates vary based
on socio-economic profile and drinking status.
At 6 months after the due birth date of the participant,
the project manager will again contact the RMSO to
check whether the participant has experienced a stillbirth
or loss after birth, and any such cases will be excluded
from follow-up data collection without further contact.
Birth outcome data (covering birth weight, gestational age
at delivery, presence of congenital anomaly and fetal loss,
or loss after birth if appropriate) will also be abstracted
and recorded on a case report form. The project manager
will then follow up eligible participants by telephone to
ascertain longer-term follow-up rates. The screening and
outcome measurement tools (the TLFB, EQ-5D-3 L &
NHS service use questionnaires) will be re-administered,
and open response questions will be asked about the
acceptability of the instruments.
Economic evaluation
The pilot study will rehearse how the relative costs and
benefits of the intervention compared with the control
group will be assessed from the perspective of the NHS
in a definitive trial. It will also explore the appropriate
use and application of data-collection instruments, to
allow the economic analysis for a definitive trial to be
structured.
This pilot study will test the collection of health-state
utilities for each participant because a cost-utility
analysis will be performed in the definitive trial. The
main analysis will measure the incremental cost per
quality adjusted life year (QALY) at the end of the trialfollow-up period. QALYs will be based upon the
responses to the EQ-5D-3 L, which is a standardized
instrument with a three- level variance for use as a
measure of health outcomes. Responses will be gathered
at baseline and both follow-ups, and converted into
QALYs using the area under the curve method [46].
To obtain the costs of the intervention, participating
GP practices will be contacted about the type of room
used for the delivery of intervention and any related
booking costs. A case report form will be used to record
the time for the alcohol counselor to book the intervention
and to hold the intervention itself. The costs of
intervention-related resource use will be obtained from
each participating center or constructed based on the unit
costs of health and social care (that is, the personal social
services research unit). Within the pilot study, the com-
pleteness of data recorded from all sources and the appro-
priateness of the data-collection tools will be assessed.
Data will be collected at post-partum follow-up inter-
views regarding the use of NHS resources. Use of
primary-care services includes antenatal and postnatal
contact with midwives, GPs, practice nurses, community
psychiatric nurses, dietitians, social workers and other
uses relating to primary care (but not of the use of
services specifically for treatment of alcohol misuse).
Use of secondary care services includes non-intervention
protocol, in-patient visits and stays, out-patient visits,
visits to accident and emergency departments, readmissions
relating to pregnancy, and other secondary care services
(also excluding treatment of alcohol misuse).
Sample-size considerations
This is a pilot trial and therefore a formal power calcula-
tion is not required. However, providing data for the
power calculation of a definitive trial is an important
function of a pilot study, and a minimum number of 30
participants per group is recommended to estimate a
parameter for this purpose [47]. We therefore aim to
screen 2,742 women to arrive at a sample of 60 provid-
ing data at the 6-month follow-up. This is based on an
estimate from the UK Infant Feeding Survey 2005 [7]
that 220 (8%) of those screened will screen positive. We
expect 10% of these to be ineligible because of substance
use [48] and 20% because of other exclusion criteria,
leaving 70% (154) eligible for the study. We estimate,
based on rates in a comparable study in the US [26], that
78% (n = 120) of this remainder will consent to enter the
pilot RCT, with 60 participants in each of the interven-
tion and control arms. This should provide data from at
least 30 women in each group at follow-up, allowing for
33% attrition in the first wave [47] and 25% in the
second wave (Figure 1). In this way, screening and inter-
vention sample sizes will be sufficient to estimate the
actual recruitment and retention rates for a UK sample
Randomisation by midwife
Intervention midwivesControl midwives
Screen positive: n=110A
Consent to study; receive usual care from 
midwife: n=60C
Consent to study; receive structured advice 
from midwife & brief intervention from 
alcohol counsellor: n=60C
Meet inclusion criteria: n=77B Meet inclusion criteria: n=77B
Screen positive: n=110A
1371 women screened by midwife
(11 per midwife per month, over 8 months) 
1371 women screened by midwife
(11 per midwife per month, over 8 months) 
Attrition 33%DAttrition 33%D
Followed to 3rd trimester n=40 Followed to 3rd trimester n=40
Attrition 25%EAttrition 25%E
Followed to 6 months postpartum n=30 Followed to 6 months postpartum n=30
Figure 1 Flow diagram for the pilot study. Based on previous data [7], we expect (A) 8% to screen positive [7]; (B) 10% to be ineligible
because of substance use [47] and 20% to be ineligible because of other exclusion criteria. In addition, we expect, based on a comparable US
study [26] , (C) a 22% refusal rate [27] and (D) a 33% attrition rate at first follow-up [46]. At second follow-up we conservatively estimate (E) a
25% attrition rate.
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provide data on the acceptability of study processes and
outcome measures [47].
Feasibility criteria are recommended for pilot study
design [49]. Support for continuing to a main trial will
constitute either: 1) recruitment rate of 78% of those eli-
gible, and retention of 67% and 75% of participants at
the two follow-up stages respectively; or 2) a finding
that, although not achieved in the pilot phase, these
rates would be likely to be achieved with feasible modifi-
cations to the trial materials or procedures.
Planned analysis
As this study is a pilot study, no formal hypothesis will
be tested. The aim of the study is to provide robust
estimates of the likely rates of recruitment, consent, and
retention, and also estimates of the variability of the
primary and secondary outcomes to help power calcula-
tions for a subsequent full-scale RCT.
The summaries of all baseline characteristics will be
presented by treatment group. The summary statistics
will be computed for all primary and secondary outcome
variables. For all continuous variables, the mean, standard
deviation, median, and range will be computed for both the
intervention and control groups. For categorical variables,
the frequencies and proportions will be calculated. The
proportion and the 95% confidence intervals will be
presented for the estimates of response, positive screening
and eligibility rates, and recruitment and retention rates.Although the study is not powered, the effect of brief
intervention will be analyzed using basic exploratory
analysis to compare the intervention and control group
using the t-test and χ2 tests. The outcome analysis will
also include the computation of economic analysis in the
pilot trial, which will allow the assessment of effectiveness
and cost-effectiveness in a full trial. The estimates of the
outcome variables of this trial will be used for calculation
of the sample size for the full trial. SPSS software (IBM
version 17.00; SPSS Inc., Chicago, IL, USA) [50] will be
used for all the statistical analyses.
Other aspects of trial design will be confirmed based
on the acceptability of the study processes and outcome
measures to the pregnant women and the midwives
responsible for their care.
Ethical and research governance approval
The study has been granted a favorable ethical opinion
by Newcastle & North Tyneside 2 NHS Research Ethics
Committee (MREC reference number: 11/NE/0205).
Project timescale
The trial duration is 30 months, starting from 1 September
2011. Screening began at the end of January 2012.
Discussion
Findings from this pilot study will indicate whether and
how a definitive trial can establish the effectiveness and
cost-effectiveness of screening and brief intervention to
Wilson et al. Trials 2012, 13:174 Page 8 of 9
http://www.trialsjournal.com/content/13/1/174reduce heavy drinking among pregnant women in the
UK. The outcomes will include the protocol for such a
trial, with a sample-size calculation, which can usefully
extend the evidence base in this field at an international
level.
Screening with brief interventions in healthcare set-
tings is increasingly recognized as an effective approach
to improving public health, and is prioritized in the UK
government’s recent alcohol strategy [16]. However,
knowledge of how effects vary across models and modes
of delivery, populations, and settings is limited [51].
Several features of this research are noteworthy in this
respect. Alcohol screening and brief intervention
involves communicating relatively long-term risk to an
individual’s own health, and advising that individual on
how to bring their drinking in line with recommended
guidelines to reduce that risk [18]. By contrast, brief
intervention against heavy drinking in pregnant women
seeks to achieve change to a lower level of consumption
than the universal guidelines to reduce short-term risk
to the pregnancy; even a change during the limited
period of pregnancy and early infancy can be considered
a successful outcome in this respect. Furthermore,
alcohol use is a particularly stigmatized issue to discuss
with pregnant women [52-54]. For this reason, com-
pared with the wider population, pregnant women may
be more anxious for guidance [55], or more reluctant to
engage in talk about alcohol, and these attitudes may
affect their willingness to participate in a trial. Finally,
much of the evidence base for brief interventions comes
from primary healthcare settings. Community midwives
have a distinct role and relationship from other health
professionals in that they are not treating diseases or
disorders, but facilitating the processes of pregnancy and
childbirth. However, there are considerable constraints
on their time with each patient. Findings from this study
will contribute to the broader understanding of screening
and brief intervention and related research by indicating
how the trial of an intervention focused on pregnancy is
likely to be received by women and midwives in the novel
healthcare setting of community antenatal care.
Trial status
The trial is currently recruiting.
Additional file
Additional file 1: RADiANT Brief Advice Tool version 1.0, for use by
midwives in the intervention condition.
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